{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:07:12Z","timestamp":1793729232555,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":56,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ygyno.2020.09.024","type":"journal-article","created":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T23:23:12Z","timestamp":1600644192000},"page":"649-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes"],"prefix":"10.1016","volume":"159","author":[{"given":"Kim E.","family":"Kortekaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Bastiaannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena C.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy J.","family":"de Vos van Steenwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Ewing-Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carien L.","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadir","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Nooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd H.","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjalling","family":"Bosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette I.E.","family":"van Poelgeest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ygyno.2020.09.024_bb0005","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1016\/j.ejca.2013.08.003","article-title":"Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma","volume":"49","author":"Schuurman","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2020.09.024_bb0010","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.AOG.0000210268.57527.a1","article-title":"Trends in the incidence of invasive and in situ vulvar carcinoma","volume":"107","author":"Judson","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.024_bb0015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ygyno.2020.01.029","article-title":"Trends in HPV-dependent and HPV-independent vulvar cancers: the changing face of vulvar squamous cell carcinoma","volume":"157","author":"Eva","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.024_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.critrevonc.2006.06.009","article-title":"Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer","volume":"60","author":"Gadducci","year":"2006","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.024_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijgo.2009.02.011","article-title":"Revised FIGO staging for carcinoma of the vulva","volume":"105","author":"Hacker","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.024_bb0030","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/IGC.0000000000000975","article-title":"European Society of Gynaecological Oncology Guidelines for the management of patients with vulvar Cancer","volume":"27","author":"Oonk","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.024_bb0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/IGC.0b013e31823eed4c","article-title":"Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment","volume":"22","author":"Woelber","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.024_bb0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ijgc-00009577-200307000-00019","article-title":"Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions","volume":"13","author":"Gaarenstroom","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"22","key":"10.1016\/j.ygyno.2020.09.024_bb0045","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1158\/1078-0432.CCR-17-1302","article-title":"Genomic characterization of vulvar (pre)cancers identifies distinct molecular subtypes with prognostic significance","volume":"23","author":"Nooij","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.024_bb0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ygyno.2018.03.003","article-title":"Vulvar cancer: two pathways with different localization and prognosis","volume":"149","author":"Hinten","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.pgp.0000177646.38266.6a","article-title":"Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways","volume":"25","author":"van der Avoort","year":"2006","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2014.11.002","article-title":"Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature","volume":"136","author":"Trietsch","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0065","doi-asserted-by":"crossref","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.024_bb0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2009.12.031","article-title":"Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node","volume":"117","author":"Lindell","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2020.09.024_bb0075","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/IGC.0b013e31826a0471","article-title":"Human papillomavirus (HPV) and HPV 16-variant distribution in vulvar squamous cell carcinoma in Sweden","volume":"22","author":"Larsson","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2020.09.024_bb0080","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1158\/1055-9965.EPI-09-0209","article-title":"The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned","volume":"18","author":"van de Nieuwenhof","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2020.09.024_bb0085","first-page":"S90","article-title":"Cancer of the vulva","volume":"119","author":"Hacker","year":"2012","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.024_bb0090","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/his.13205","article-title":"Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study","volume":"71","author":"McAlpine","year":"2017","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/his.14109","article-title":"Performance of the pattern based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma","volume":"77","author":"Kortekaas","year":"2020","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.ygyno.2020.09.024_bb0100","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","article-title":"Major p53 immunohistochemical patterns in in-situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status","volume":"33","author":"Tessier-Cloutier","year":"2020","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.bjc.6605112","article-title":"Modest effect of p53, EGFR and HER-2\/neu on prognosis in epithelial ovarian cancer: a meta-analysis","volume":"101","author":"de Graeff","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"16","key":"10.1016\/j.ygyno.2020.09.024_bb0110","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","article-title":"Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva","volume":"49","author":"de Sanjose","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PGP.0b013e31826916c7","article-title":"The lower Anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"32","author":"Darragh","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.024_bb0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/annonc\/mdz010","article-title":"Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma","volume":"30","author":"Rasmussen","year":"2019","journal-title":"Ann. Oncol."},{"issue":"7\u20138","key":"10.1016\/j.ygyno.2020.09.024_bb0125","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/sim.3762","article-title":"Estimating the crude probability of death due to cancer and other causes using relative survival models","volume":"29","author":"Lambert","year":"2010","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.024_bb0130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ije\/dyp392","article-title":"Measuring cancer survival in populations: relative survival vs cancer-specific survival","volume":"39","author":"Sarfati","year":"2010","journal-title":"Int. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.ygyno.2020.09.024_bb0135","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ejca.2013.09.019","article-title":"Choosing the net survival method for cancer survival estimation","volume":"51","author":"Seppa","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"15","key":"10.1016\/j.ygyno.2020.09.024_bb0140","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.ejca.2007.08.005","article-title":"Clinical epidemiology of breast cancer in the elderly","volume":"43","author":"Louwman","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.09.024_bb0145","series-title":"Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions","first-page":"522","volume":"13(4)","author":"Gaarenstroom","year":"2003"},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.024_bb0150","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1521-6934(03)00050-6","article-title":"Local and regional recurrence of vulval cancer: management dilemmas","volume":"17","author":"Coulter","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2020.09.024_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ijgo.12609","article-title":"Cancer of the vulva","volume":"143","author":"Rogers","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.024_bb0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/gyno.1995.1151","article-title":"The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients","volume":"57","author":"Burger","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.024_bb0165","unstructured":"Singh, N., et al., p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. J. Pathol., (in press)."},{"issue":"12","key":"10.1016\/j.ygyno.2020.09.024_bb0170","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/cncr.11837","article-title":"The value of routine follow-up in patients treated for carcinoma of the vulva","volume":"98","author":"Oonk","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0175","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/ijgc-2019-000793","article-title":"Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma","volume":"30","author":"Proctor","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2018.08.014","article-title":"The prognostic significance of p16 status in patients with vulvar Cancer treated with Vulvectomy and adjuvant radiation","volume":"103","author":"Dohopolski","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2018.08.002","article-title":"Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy","volume":"151","author":"Horne","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0190","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s40425-019-0712-z","article-title":"High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status","volume":"7","author":"Kortekaas","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ygyno.2020.09.024_bb0195","series-title":"AJCC Cancer Staging Manual 8th Edition","author":"Amin","year":"2017"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.024_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamaoncol.2018.4051","article-title":"Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16-related Cancer: a phase 2 clinical trial","volume":"5","author":"Massarelli","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ygyno.2020.09.024_bb0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41199-018-0039-3","article-title":"HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis","volume":"3","author":"Pan","year":"2018","journal-title":"Cancers Head Neck"},{"issue":"7","key":"10.1016\/j.ygyno.2020.09.024_bb0210","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1470-2045(10)70104-2","article-title":"Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study","volume":"11","author":"Oonk","year":"2010","journal-title":"Lancet Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820339172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820339172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:53:19Z","timestamp":1758772399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820339172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0090825820339172"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.024","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}